Trial intelligence / Profile preview

Placebo-Controlled Study of SPM962 Transdermal Patch in Idiopathic Restless Legs Syndrome

jRCT2080220569Phase 2

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Jun 2008
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in restless legs syndrome (RLS) (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.

02

Conditions

restless legs syndrome (RLS)

Beyond the preview

Go deeper on jRCT2080220569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call